Boothbay Fund Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-30,236
| Closed | -$426K | – | 1945 |
|
|
2023
Q2 | $426K | Hold |
30,236
| – | – | 0.01% | 989 |
|
|
2023
Q1 | $467K | Sell |
30,236
-36,782
| -55% | -$568K | 0.01% | 1075 |
|
|
2022
Q4 | $1.1M | Sell |
67,018
-18,271
| -21% | -$299K | 0.03% | 700 |
|
|
2022
Q3 | $1.58M | Buy |
+85,289
| New | +$1.58M | 0.04% | 583 |
|
|
2022
Q1 | – | Sell |
-21,563
| Closed | -$211K | – | 2267 |
|
|
2021
Q4 | $211K | Buy |
21,563
+13,720
| +175% | +$134K | 0.01% | 1299 |
|
|
2021
Q3 | $267K | Buy |
7,843
+826
| +12% | +$28.1K | 0.01% | 1168 |
|
|
2021
Q2 | $257K | Buy |
+7,017
| New | +$257K | 0.01% | 1220 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1630 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1326 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1166 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1025 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1022 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 949 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 854 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 844 |
|
|
2019
Q1 | – | Sell |
-30,454
| Closed | -$639K | – | 825 |
|
|
2018
Q4 | $639K | Buy |
30,454
+17,902
| +143% | +$376K | 0.09% | 169 |
|
|
2018
Q3 | $486K | Buy |
+12,552
| New | +$486K | 0.05% | 277 |
|